First-in-human trial of 4′-thio-2′-deoxycytidine (TdCyd) in patients with advanced solid tumors

被引：3

作者：

Coyne, G. O'Sullivan ^{[1
]}

Chen, A. ^{[1
]}

Kummar, S. ^{[2
]}

Collins, J. M. ^{[3
]}

Meehan, R. S. ^{[1
]}

Suto, M. ^{[4
]}

Rubinstein, L. ^{[5
]}

Kinders, R. ^{[6
]}

Moore, N. ^{[7
]}

Parchment, R. ^{[6
]}

Horneffer, Y. ^{[1
]}

Juwara, L. ^{[7
]}

Difilippantonio, M. ^{[3
]}

Piekarz, R. ^{[1
]}

Doroshow, J. ^{[3
]}

机构：

[1] NCI, Dev Therapeut Clin, Div Canc Treatment & Diag, Bethesda, MD 20892 USA

[2] Stanford Univ, Div Oncol, Phase Clin Res 1, Palo Alto, CA 94304 USA

[3] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA

[4] Southern Res Inst, Drug Discovery Div, Birmingham, AL USA

[5] NCI, Biometr Res Program, Bethesda, MD 20892 USA

[6] Frederick Natl Lab Canc Res, Appl Dev Res Directorate, Frederick, MD USA

[7] Leidos Biomed Res, Clin Monitoring Res Program, Bethesda, MD USA

来源：

关键词：

D O I：

10.1093/annonc/mdw368.54

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

411TiP

引用

页数：1